AzTrials
AzTrials

Prolonged Grief DisorderBALANCENCT05274841

Systematic Support for Relatives of Palliative Care Patients

A study testing Support of relatives in people with Prolonged Grief Disorder, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The primary purpose of this study is to validate the prognostic screening tool from The Aarhus Bereavement Study (TABS) and to implement a systematic support for relatives of palliative care patients in order to prevent the development of prolonged grief disorder. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Prolonged Grief Disorder
What is being tested?
Support of relatives
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteDenmark
Study dates
1 Jan 2021to 1 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • relatives of palliative care patients with relation to Department of Palliative Care, (Rigshospitalet)
  • relatives identified by the patient

Who cannot join

  • relatives who do not read or understand danish
  • relatives who are cognitive disabled

Trial locations and contacts

1 site in 1 country.

Denmark1 site, 1 recruiting
  • Julie Høgh Rasmussen

    Copenhagen, Vesterbro, 1721

    Julie Høgh Rasmussen, Cand.Psych.Aut., +4528707323, julie.hoegh.rasmussen@regionh.dk

    Louise Laursen, Cand.Scient.Sand., +4521449323, louise.laursen@regionh.dk

    Recruiting

Other trials in Denmark

About this study

Official title: Implementation of Systematic Support of Relatives of Palliative Care Patients : a Cohort Study

The primary purpose of this study is to validate the prognostic screening tool from The Aarhus Bereavement Study (TABS) and to implement a systematic support for relatives of palliative care patients in order to prevent the development of prolonged grief disorder. Depending on their identified support needs, the relatives are offered different interventions. It is evaluated whether this procedure of screening and intervening are able to reduce the risk of developing prolonged grief disorder.

Read the detailed description

PRIMARY OUTCOME: identification of the support needs of relatives of palliative care patients

SECONDARY OUTCOME: evaluation of the initiated interventions and whether these are able to reduce the risk of developing prolonged grief disorder

PARTICIPANTS: Relatives (age 18-90) of patients affiliated with specialized palliative care in The Capital Region of Denmark.

The relatives will complete a survey and prognostic screening tool at respectively 2 weeks (T1) and every 6 months (T2) from the time that the patients is affiliated to the specialized palliative care and until the death of the patient. This will happen regardless the status of the patient - that is, whether or not the patient continues being affiliated with specialized palliative care, or the patient is being referred to another palliative care units or doesn't need palliative care anymore.

Furthermore the relatives will complete a follow-up survey and the diagnostic questionnaire PGD-13 at respectively 6 months (T3) and 18 months (T4) after the death of the patient (post loss). It will be evaluated whether there are any diffences in the grief symptoms of relatives of patients with a malign versus non-malign disease. It will also be evaluated whether there is an association between the intervention the relatives received from the palliative care unit at Rigshospital and their grief symptoms post loss.

Being tested
Support of relatives
Keywords
Palliative Care, Screening tool, Assessment tool, Relatives, Support needs, Anticipatory Grief, Palliative patients, Caregivers
Medical subject headings
Prolonged Grief Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Support of relativesOther

    Screening of the support needs of relatives

Study groups in NCT05274841
Study groupRoleWhat they receive
Identified support needsOtherIdentified need of either support from a psychologist, nurse, doctor, socialworker or a combination of theese.
Receives: Other: Support of relatives

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Support needs of relatives of palliative patients (baseline)

    Identification of support needs of relatives assessed by the prognostic screening tool from The Aarhus Bereavement Study (TABS).

    Measured: 1 month from the time that the patient is referred to the palliative care team.

  2. Change in Support needs of relatives of palliative patients from baseline

    Identification of support needs of relatives assessed by the prognostic screening tool from

    Measured: 6 months

  3. Change in Support needs of relatives of palliative patients from baseline

    Identification of support needs of relatives assessed by the prognostic screening tool from

    Measured: 12 months

  4. Change in Support needs of relatives of palliative patients from baseline

    Identification of support needs of relatives assessed by the prognostic screening tool from

    Measured: 18 months

Secondary outcomes (2)
  1. Prolonged grief

    Symptoms of prolonged grief measured using the Prolonged Grief Disorder - 13 (PG-13, Prigerson et al, 2009). Scores ranging from 11 to 55 are used in the current study, and a higher score indicates a worse outcome. However, there are no officially recommended cut-off scores (Pohlkamp et al, 2018).

    Measured: 6 months post-loss.

  2. Prolonged grief

    Symptoms of prolonged grief measured using the Prolonged Grief Disorder - 13 (PG-13, Prigerson et al, 2009). Scores ranging from 11 to 55 are used in the current study, and a higher score indicates a worse outcome. However, there are no officially recommended cut-off scores (Pohlkamp et al, 2018).

    Measured: 18 months post-loss.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Mar 2022
  2. Study start1 Jan 2021
  3. Primary completion1 Jan 2025 (estimated)
  4. Study completion1 Jan 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05274841
Sponsor's protocol ID
P-2020-429
Acronym
BALANCE
Status last verified
Mar 2022
First submitted
28 Jan 2022
Last updated
11 Mar 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Support of relatives in people with Prolonged Grief Disorder, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Support needs of relatives of palliative patients (baseline) (time frame: 1 month from the time that the patient is referred to the palliative care team.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in